GR1014 Cutaneous Gel, The placebo ingredients are identical to those of GR1014-CG with the exception that the drug clinical trials

A randomized, double-blind, vehicle-controlled, multi-centre, parallel-group study to investigate the safety, tolerability, and efficacy of GR1014 cutaneous gel as a topical radioprotector in the prevention of the radiodermatitis occurring with adjuvant radiotherapy for localized breast cancer after lumpectomy

This study looks at a gel called GR1014. It aims to see if this gel can help prevent or reduce painful skin reactions caused by radiotherapy for breast cancer. The gel is applied to the skin during treatment.